Rapid treatment of sepsis using mandated care bundles improves outcomes.
Older age and peaked tympanogram are associated with reduced risk of treatment failure in young children with acute otitis media.
Vabomere, formerly known as Carbavance, is approved for patients with complicated UTI including pyelonephritis.
The addition of bismuth subcitrate to levofloxacin-based triple therapy is not associated with increased effectiveness in patients with Helicobacter pylori infection.
The FDA has given Fast Track designation to an oral drug candidate for treating Valley Fever.
Meningococcal disease risk has been linked to eculizumab despite previous vaccination.
Using antimicrobial dressing instead of a non-antimicrobial dressing may increase healing of diabetic foot ulcers.
The WHO issued a new list of essential medicines for 2017, adding new treatments for HIV, hepatitis C virus, and tuberculosis.
Studies sought to describe the effects of teriflunomide treatment on lymphocyte counts and infection rates in relapsing forms of multiple sclerosis (MS).
Researchers find that the spread of triazole-resistant Aspergillus fumigatus is linked to plant bulbs.
Researchers found that viruses were the most common cause of meningitis and encephalitis in the United States from 2011 to 2014.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Guideline Update: Influenza Immunization Recommendations for 2017-2018
- Update on Pediatric HCV: Screening, Treatment, and Other Considerations
- Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB
- HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes
- DAAs Effective for HCV in Patients With Thalassemia
- Mycoplasma genitalium: Challenges in Diagnosis and Treatment
- FDA: Vabomere Approved for Complicated UTI Following Priority Review
- Update on Safe, Effective Treatments for Latent Tuberculosis Infection
- New CDC Guidelines for SSI Prevention Leave Unanswered Questions
- Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection